Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Short-Term Debt issuances (2019 - 2024)

AdaptHealth (AHCO) has 5 years of Short-Term Debt issuances data on record, last reported at $178.5 million in Q3 2024.

  • For Q3 2024, Short-Term Debt issuances changed N/A year-over-year to $178.5 million; the TTM value through Jun 2025 reached $178.5 million, up 42.78%, while the annual FY2024 figure was $253.5 million, 406.95% up from the prior year.
  • Short-Term Debt issuances reached $178.5 million in Q3 2024 per AHCO's latest filing, up from $75.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $795.0 million in Q1 2021 and bottomed at $50.0 million in Q1 2023.
  • Average Short-Term Debt issuances over 4 years is $228.9 million, with a median of $95.0 million recorded in 2021.
  • The widest YoY moves for Short-Term Debt issuances: up 1035.71% in 2021, down 79.63% in 2021.
  • A 4-year view of Short-Term Debt issuances shows it stood at $55.0 million in 2020, then skyrocketed by 72.73% to $95.0 million in 2021, then tumbled by 47.37% to $50.0 million in 2023, then soared by 256.95% to $178.5 million in 2024.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were $178.5 million in Q3 2024, $75.0 million in Q1 2024, and $50.0 million in Q1 2023.